Michael Adasczik
Comptroller/Controller/Auditor chez B&G FOODS, INC.
Fortune : 187 890 $ au 31/05/2024
Profil
Michael D.
Adasczik is currently the Chief Accounting Officer & Vice President-Finance at B&G Foods, Inc. Prior to this, he worked as the Principal Accounting Officer at Sio Gene Therapies, Inc. from 2015 to 2018.
Adasczik holds an undergraduate degree and an MBA from Rider University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
B&G FOODS, INC.
0,02% | 25/03/2024 | 19 695 ( 0,02% ) | 187 890 $ | 31/05/2024 |
Postes actifs de Michael Adasczik
| Sociétés | Poste | Début |
|---|---|---|
| B&G FOODS, INC. | Comptroller/Controller/Auditor | 12/11/2018 |
Anciens postes connus de Michael Adasczik
| Sociétés | Poste | Fin |
|---|---|---|
| SIO GENE THERAPIES INC. | Comptroller/Controller/Auditor | 01/06/2018 |
Formation de Michael Adasczik
| Rider University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| B&G FOODS, INC. | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
